助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   percutaneous coronary interventions 的翻译结果: 查询用时:0.013秒
图标索引 在分类学科中查询
所有学科
心血管系统疾病
急救医学
临床医学
更多类别查询

图标索引 历史查询
 

percutaneous coronary interventions
相关语句
  经皮冠状动脉介入
     Objectives To explore the clinical effects of percutaneous coronary interventions (PCI) on elderly patients with acute coronary syndrome (ACS) who were all more than 65 years old.
     目的探讨65岁以上急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)的临床疗效。
短句来源
     Percutaneous coronary interventions (PCI),radiogrequency ablations (RFA) and implantation of pacemakers accounted for 56 34%,22 49% and 17 00% of the total therapeutic procedures.
     经皮冠状动脉介入治疗 (PCI)、射频消融术 (RF)和起搏器植入术分别占总介入治疗量的 5 6 34%、2 2 4 9%和 17 0 0 %。
短句来源
     Nursing and Observation of Bleeding After Percutaneous Coronary Interventions
     经皮冠状动脉介入术后出血观察与护理
短句来源
     A Clinical Study on the Impact of Percutaneous Coronary Interventions on Left Ventricular Function in the Patients With Acute Myocardial Infarction
     经皮冠状动脉介入治疗对急性前壁心肌梗死患者左心室功能作用的临床研究
短句来源
     Objective To study the effects of delayed percutaneous coronary interventions (PCI) on left ventricular remodeling (LVRM) after acute myocardial infarction (AMI).
     目的 探讨急性心肌梗死 (AMI)后择期经皮冠状动脉介入治疗 (PCI)对左心室重构 (LVRM)的影响。
短句来源
更多       
  冠状动脉介入
     Complications in selective percutaneous coronary interventions:analysis of 2868 cases
     择期冠状动脉介入治疗2868例并发症分析
短句来源
     Objectives To explore the clinical effects of percutaneous coronary interventions (PCI) on elderly patients with acute coronary syndrome (ACS) who were all more than 65 years old.
     目的探讨65岁以上急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)的临床疗效。
短句来源
     Percutaneous coronary interventions (PCI),radiogrequency ablations (RFA) and implantation of pacemakers accounted for 56 34%,22 49% and 17 00% of the total therapeutic procedures.
     经皮冠状动脉介入治疗 (PCI)、射频消融术 (RF)和起搏器植入术分别占总介入治疗量的 5 6 34%、2 2 4 9%和 17 0 0 %。
短句来源
     Objective To analyse the risk factors, prevention and treatments of the complications of percutaneous coronary interventions (PCI) Methods The types, the incidence and the annual distribution characteristics of the complications of coronary interventions performed from 1988 to 2003 were reviewed retrospectively, and the risk factors analyzed Results During the study period, 1?
     目的 总结分析我院心内科冠状动脉介入治疗 (PCI)的并发症发生率、发生原因和防治措施。 方法 应用回顾性调查的方法对在本院心内科于 1988年 10月至 2 0 0 3年 12月冠心病介入治疗的主要并发症类型、发生率及其年度分布特征进行统计分析 ,并进一步分析与严重并发症发生有关的危险因素。
短句来源
     Nursing and Observation of Bleeding After Percutaneous Coronary Interventions
     经皮冠状动脉介入术后出血观察与护理
短句来源
更多       
  “percutaneous coronary interventions”译为未确定词的双语例句
     Therefore in-stent restenosisis is considered as an important problem to be solved during percutaneous coronary interventions (PCI).
     因此,它是目前PCI(percutaneous coronary interventions,冠心病介入治疗)中急需解决的重要问题。
短句来源
     Clinical Value of Percutaneous Coronary Interventions in Female Patients with non-ST-elevation Acute Coronary Syndrome
     女性非ST段抬高急性冠脉综合征PCI干预的临床评价
短句来源
     Percutaneous coronary interventions for acute non-Q-wave myocardial infarction
     急性非Q波型心肌梗死的介入治疗
短句来源
     Methods 68 patients with acute coronary syndrome (ACS)appeared no-reflow phenomenon of the target vessel during percutaneous coronary interventions,and were given nitroglycerin to coronary artery firstly. 64 patients(94.11%)had no improvement and were divided into 3 groups at random:A group,21 cases, were given the urokinase(10 -50)×10~4 U and verapamil 0.5~1.5 mg by alternate injection to coronary artery;
     方法68例急性冠脉综合征(ACS)患者实施冠脉介入治疗时出现靶血管的无再流现象,首先予冠脉内硝酸甘油,其中64例(94.11%)血流无改善,随机将该64例分为三组:A组(21例):交替给予尿激酶(10~50)×10~4 U及维拉帕米0.5~1.5 mg冠脉内注射;
短句来源
     Methods Data were collected as a part of a prospective registry of all percutaneous coronary interventions performed by authors between January 2001 and October 2002. Comparisons between 2 age groups (≥70 years and <70 years) were performed using chi-square tests.
     方法 本院 2 0 0 1年 1月至 2 0 0 2年 10月间的PCI手术病例登记资料 ,2个年龄组 (年龄≥ 70岁及 <70岁 )之间的比较用卡方检验。
短句来源
更多       
查询“percutaneous coronary interventions”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  percutaneous coronary interventions
Glycoprotein (GP) IIb/IIIa inhibitors reduce major adverse coronary events in patients with acute coronary syndromes undergoing percutaneous coronary interventions (PCI).
      
Glycoprotein (GP) IIb/IIIa inhibitors have been shown to reduce morbidity and mortality in patients with acute coronary syndromes undergoing percutaneous coronary interventions (PCI).
      
One approach is the resurgent use of facilitated percutaneous coronary interventions (PCI).
      
The initial studies of hirudin and bivalirudin in the clinical settings of acute myocardial infarction (AMI), unstable angina (UA) and percutaneous coronary interventions (PCI) conducted in the early 1990s proved to be disappointing.
      
Background: Previous studies have demonstrated a prolongation of activated clotting times (ACT) with abciximab administration during percutaneous coronary interventions (PCI).
      
更多          


AIM To evaluate the success rate and incidence of complications of percutaneous coronary interventions in Xijing hospital. METHODS The data were collected from all patients with percutaneous coronary interventions from 1985 to 1998 in Xijing Hospital. Only patients with complete case data were analyzed. RESULTS Of 537 patients treated withcoronary interventions, 69.3% had unstable angina,20.3% had depressed left ventricular function (LVEF≤40%), 64 6% had multivessel disease. Coronary...

AIM To evaluate the success rate and incidence of complications of percutaneous coronary interventions in Xijing hospital. METHODS The data were collected from all patients with percutaneous coronary interventions from 1985 to 1998 in Xijing Hospital. Only patients with complete case data were analyzed. RESULTS Of 537 patients treated withcoronary interventions, 69.3% had unstable angina,20.3% had depressed left ventricular function (LVEF≤40%), 64 6% had multivessel disease. Coronary angioplasty was attempted in 671 vessels and 769 lesions (type A: 22.1%; B: 44.6%; C: 31.3%). The patient success rate was 89.2%; The success rate for lesions was 89.1%. The incidence of major complications was 3 4%, including 1.9% of death, 2 0% of Q wave infarction, and 0.2% of emergency bypass surgery. Coronary stenting was widely used from January, 1995. Although coronary disease in patients during 1995~1998 was more severe than those during 1985~1994, the patient success rate was higher (91% vs 80%, P <0.01), and the incidence rate of major complications was lower (2.6% vs 6.4%, P <0.05). CONCLUSION Although patients with percutaneous coronary interventions are severe in our center, the success rate and incidence rate of major complications are comparable with those reported in foreign literature. The widespread use of stenting has improved the safety of coronary interventions.

目的 总结西京医院冠心病介入治疗的成功率及并发症发生率 .方法 回顾性分析 1998- 12前所有冠心病介入治疗病历完整患者的临床资料 .结果 在 5 37例患者中 ,6 9.3%为不稳定性心绞痛 ,2 0 .3%射血分数≤ 40 .0 % ,6 4.6 %为多支病变 .治疗血管 6 71支、病变 76 9处 ,B,C型病变77.9% .介入治疗病例成功率为 89.2 % .病变成功率 89.1% ,严重并发症发生率为 3.4% (死亡 1.9% ,Q波心梗 2 .0 % ,急症冠脉搭桥术 0 .2 % ) .普遍应用支架前后对比 ,病例成功率提高 (91.0 % vs80 .0 % ,P<0 .0 1) ,严重并发症发生率下降 (2 .6 % vs 6 .4% ,P<0 .0 5 ) .结论 我院病例病情严重 ,介入治疗成功率和并发症发生率与国外文献报道相似 .支架提高了介入治疗的安全性

Objective To investigate the role of a certain density of low power red laser for prevention of restenosis following coronary angioplasty. Methods 55 patients were divided randomly into tow groups: PTCA group (control group) and PTCA plus intracoronary low power red laser illumination group (treatment group). The density of red laser illumination was 0 9 J/cm 2 All patients received clinical follow-up and some of the patients received repeated coronary angiography within 6 months. Results ...

Objective To investigate the role of a certain density of low power red laser for prevention of restenosis following coronary angioplasty. Methods 55 patients were divided randomly into tow groups: PTCA group (control group) and PTCA plus intracoronary low power red laser illumination group (treatment group). The density of red laser illumination was 0 9 J/cm 2 All patients received clinical follow-up and some of the patients received repeated coronary angiography within 6 months. Results TIMI 3 flows were achieved in all cases and residual stenosis was less than 30%. No severe complications were found. At the end of 6 months follow-up, there was 4 cases in treatment group and 7 case in control group experienced recurrent angina respectively. 39 patients received repeated coronary angiography. Of which only one case in treatment group but five patients in control group expressed restenosis. There were significant differences in amplitude of decreasing in minimal lumen diameter between tow groups. The other 16 cases who didn′t received repeated coronary angiography remained symptom-free with negative treadmill exercise test. No major clinical events were found in all cases during follow up.Conclusion Low power red laser illumination can achieve low restenosis rate after percutaneous coronary intervention without complication. However, a large randomized study is necessary to further evaluate its clinical efficacy.

目的 探讨一定能量密度的低强度红激光对经皮冠脉成形术 (PTCA)后再狭窄的预防作用。方法  5 5例PTCA的患者随机分成单纯PTCA组 (对照组 ) 2 9例和PTCA加冠脉内局部低强度红激光照射组 (治疗组 ) 2 6例 ,照射的能量密度为 0 9J/cm2 。随访终点为术后 6个月。结果 所有PTCA术后血流均达到TIMI 3级 ,残余狭窄在 30 %以下 ,无发生严重并发症。到随访终点 ,治疗组有 4例患者 ,对照组有 7例患者复发心绞痛 (P >0 0 5 ) ;39例患者术后半年进行冠状动脉造影复查 ,治疗组有 1例患者 ,对照组有 5例患者出现再狭窄 (P <0 0 5 ) ;两组之间冠脉内径下降幅度差异有显著性(P <0 0 5 )。另外 16例患者因无临床症状 ,活动平板试验阴性而未再进行冠脉造影。无 1例发生急性心肌梗死或需冠状动脉搭桥术。结论 低强度红激光局部照射对冠脉成形术后再狭窄有预防作用 ,确切的疗效有待于大规模临床试验明确。

Eptifibatide,a PG Ⅱb/Ⅲa receptor antagonist,exhibits its antiplatelet action by inhibiting the final common pathway (PG Ⅱa/Ⅲa receptor) of platelet.It has the advantage of potent effect,rapid onset of action,and less side effects.Clinical study showed that it can improve the prognosis of patients with unstable angina,non Q wave myocardial infarction and patients before reception of percutaneous coronary intervention. [

Eptifibatide是一种新型的血小板糖蛋白IIb/IIIa受体拮抗剂。它通过抑制血小板聚集的最后共同途径 ,具有抗血小板作用强、起效快、不良反应少等优点。临床研究表明 ,该药对不稳定型心绞痛、非Q波型心肌梗死、冠脉内介入治疗前等患者有改善预后的有利作用

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关percutaneous coronary interventions的内容
在知识搜索中查有关percutaneous coronary interventions的内容
在数字搜索中查有关percutaneous coronary interventions的内容
在概念知识元中查有关percutaneous coronary interventions的内容
在学术趋势中查有关percutaneous coronary interventions的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社